Celanese Past Earnings Performance
Past criteria checks 2/6
Celanese has been growing earnings at an average annual rate of 14%, while the Chemicals industry saw earnings growing at 17.9% annually. Revenues have been growing at an average rate of 12.9% per year. Celanese's return on equity is 26.1%, and it has net margins of 18%.
Key information
14.0%
Earnings growth rate
17.6%
EPS growth rate
| Chemicals Industry Growth | 20.4% |
| Revenue growth rate | 12.9% |
| Return on equity | 26.1% |
| Net Margin | 18.0% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Celanese makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 10,940 | 1,969 | 1,144 | 146 |
| 30 Sep 23 | 10,719 | 2,033 | 1,014 | 151 |
| 30 Jun 23 | 10,297 | 1,273 | 928 | 144 |
| 31 Mar 23 | 9,988 | 1,494 | 824 | 130 |
| 31 Dec 22 | 9,673 | 1,902 | 690 | 112 |
| 30 Sep 22 | 9,600 | 1,662 | 658 | 98 |
| 30 Jun 22 | 9,565 | 1,989 | 627 | 94 |
| 31 Mar 22 | 9,277 | 2,091 | 578 | 90 |
| 31 Dec 21 | 8,537 | 1,912 | 527 | 86 |
| 30 Sep 21 | 7,853 | 2,837 | 552 | 83 |
| 30 Jun 21 | 6,998 | 2,527 | 502 | 81 |
| 31 Mar 21 | 5,993 | 2,095 | 466 | 77 |
| 31 Dec 20 | 5,655 | 1,997 | 464 | 74 |
| 30 Sep 20 | 5,496 | 586 | 457 | 71 |
| 30 Jun 20 | 5,671 | 645 | 482 | 69 |
| 31 Mar 20 | 6,070 | 745 | 496 | 68 |
| 31 Dec 19 | 6,297 | 858 | 502 | 67 |
| 30 Sep 19 | 6,554 | 912 | 578 | 68 |
| 30 Jun 19 | 6,739 | 1,051 | 579 | 69 |
| 31 Mar 19 | 6,991 | 1,185 | 588 | 70 |
| 31 Dec 18 | 7,155 | 1,212 | 606 | 72 |
| 30 Sep 18 | 7,059 | 1,320 | 500 | 74 |
| 30 Jun 18 | 6,854 | 1,143 | 506 | 75 |
| 31 Mar 18 | 6,520 | 1,038 | 491 | 74 |
| 31 Dec 17 | 6,140 | 856 | 451 | 73 |
| 30 Sep 17 | 5,858 | 812 | 470 | 73 |
| 30 Jun 17 | 5,615 | 847 | 441 | 74 |
| 31 Mar 17 | 5,456 | 829 | 417 | 76 |
| 31 Dec 16 | 5,389 | 902 | 416 | 78 |
| 30 Sep 16 | 5,412 | 444 | 441 | 79 |
| 30 Jun 16 | 5,502 | 340 | 453 | 78 |
| 31 Mar 16 | 5,628 | 326 | 488 | 79 |
| 31 Dec 15 | 5,674 | 306 | 506 | 80 |
| 30 Sep 15 | 5,899 | 522 | 714 | 77 |
| 30 Jun 15 | 6,255 | 619 | 739 | 80 |
| 31 Mar 15 | 6,547 | 671 | 752 | 84 |
| 31 Dec 14 | 6,802 | 631 | 758 | 86 |
| 30 Sep 14 | 6,859 | 1,369 | 336 | 80 |
| 30 Jun 14 | 6,726 | 1,282 | 315 | 82 |
| 31 Mar 14 | 6,610 | 1,156 | 309 | 81 |
| 31 Dec 13 | 6,510 | 1,101 | 311 | 85 |
| 30 Sep 13 | 6,395 | 278 | 792 | 104 |
| 30 Jun 13 | 6,368 | 236 | 808 | 103 |
Quality Earnings: C1NS34 has a large one-off gain of $430.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: C1NS34's current net profit margins (18%) are lower than last year (19.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: C1NS34's earnings have grown by 14% per year over the past 5 years.
Accelerating Growth: C1NS34's earnings growth over the past year (3.5%) is below its 5-year average (14% per year).
Earnings vs Industry: C1NS34 earnings growth over the past year (3.5%) exceeded the Chemicals industry -40.6%.
Return on Equity
High ROE: Whilst C1NS34's Return on Equity (26.13%) is high, this metric is skewed due to their high level of debt.